Clinical profiles, epidemiological characteristics and treatment outcomes of COVID-19 patients in North-eastern Ethiopia: A retrospective cohort study

Author:

Gedefie AlemuORCID,Birara Tadesse,Misganaw Sisay,Bambo Getachew Mesfin,Kebede Samuel Sahile,Tilahun Mihret,Mohammed Ousman,Kassa Yeshimebet,Bisetegn Habtye,Alemayehu ErmiyasORCID

Abstract

Background COVID-19 is a rapidly emerging global health threat and economic disaster. The epidemiology and outcomes of COVID-19 patients in Ethiopia are scarce. Thus, the present study aimed to assess clinical profiles, epidemiological characteristics, and treatment outcomes of patients with COVID-19 and to identify determinants of the disease outcome among COVID-19 patients in North-eastern Ethiopia. Methods A retrospective observational cohort study was conducted in North-eastern Ethiopia, from May 2020 to Jan 2022 on a total of 364 SARS-COV-2 infected patients. Demographic and clinical data were abstracted from the medical records of patients. Bivariable and multivariable analyses were conducted to determine the factors associated with the mortality of COVID-19 patients and variables with a P-value < 0.05 were considered statistically significant. Result Among 364 COVID-19 patients included in this study, two-thirds (68.1%) were males with a median age of 34 years. The majority; 42.9% & 33.0% respectively cases were detected at the health facility and community level surveillance. Furthermore, 6.6% of patients had pre-existing comorbidities of which diabetes mellitus (23.1%) and hypertension (15.3%) had the highest frequency. The symptomatic rate of COVID-19 patients was 30.5%. The most common clinical presentations were cough (26.9%), fever (26.1%), and shortness of breath (15.2%). Moreover, the mortality rate of COVID-19 patients was 4.1% which was independently predicted by a history of underlining co-morbidity (AHR:6.09; 95%CI:1.299–28.56; P = 0.022) and a history of severe or critical conditions (AHR 11.8; 95%CI:4.89–28.83; P = 0.003). Conclusion Severe or critical acute COVID-19 and underlining comorbidities are associated with higher mortality. Therefore, critical follow–up and management should be given to patients with underlying diseases is required.

Publisher

Public Library of Science (PLoS)

Reference37 articles.

1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/region/afro/country/et (accessed 18 March 2023).

2. SARS-CoV-2 serosurvey in Addis Ababa, Ethiopia;JH Kempen;Am J Trop Med Hyg,2020

3. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).;C Sohrabi;Int J Surg,2020

4. Clinical Characteristics of Coronavirus Disease 2019 in China;W-J Guan;N Engl J Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3